(Q43524137)

24 November 2017

Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial (English)

1 reference

Coenraad Dirk Adriaan Stehouwer

24 November 2017

0 references

1 reference

1 reference

9

object named as

C D A Stehouwer

1 reference

24 November 2017

3

C Schalkwijk

1 reference

24 November 2017

J de Jager

1

1 reference

24 November 2017

A Kooy

2

1 reference

24 November 2017

J van der Kolk

4

1 reference

24 November 2017

P Lehert

5

1 reference

24 November 2017

D Bets

6

1 reference

24 November 2017

M G Wulffelé

7

1 reference

24 November 2017

A J Donker

8

1 reference

24 November 2017

language of work or name

English

0 references

publication date

16 September 2013

1 reference

Journal of Internal Medicine

24 November 2017

1 reference

24 November 2017

275

1 reference

24 November 2017

1

1 reference

24 November 2017

59-70

1 reference

The diabetes epidemic: a national and global crisis

24 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Improved endothelial function with metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Combination of insulin and metformin in the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Endothelial dysfunction and pathogenesis of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

von Willebrand factor: a marker of endothelial damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Novel clinical markers of vascular wall inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-selectin concentrations in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Inhibition of tumor necrosis factor alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Effect of metformin on adipose tissue resistin expression in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12128

21 January 2018

Identifiers

DOI

10.1111/JOIM.12128

1 reference

24 November 2017

1 reference